Manifestations of an overdose of VARIZIG administered intramuscularly are expected to be pain and tenderness at the injection site.
- Individuals known to have anaphylactic or severe systemic (hypersensitivity) reactions to human immune globulin preparations should not receive VARIZIG.
- IgA-deficient patients with antibodies against IgA and a history of hypersensitivity may have an anaphylactoid reaction.
- VARIZIG contains less than 40 micrograms per milliliter of IgA.
Last reviewed on RxList: 3/14/2016
Additional VariZIG Information
Report Problems to the Food and Drug Administration
Find out what women really need.